Compounded Solutions in Pharmacy is recalling 13 units of Acetyl-L-Cysteine Ophthalmic Solutions (eye drops) in 5%, 10%, and 20% concentrations due to a lack of processing controls. This defect means the medication may not have been prepared under appropriate sterile conditions, which can lead to contamination. The affected eye drops were dispensed in 3ml, 5ml, 10ml, and 15ml dropper bottles directly to patients between June and August 2019.
A lack of processing controls during the compounding of eye drops can result in products that are not sterile. Using non-sterile eye drops can introduce bacteria or other contaminants directly into the eye, potentially causing serious infections or permanent vision loss.
Full refund for returned unused product.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.